Article
DNA repair gene XRCC1 polymorphisms and outcome of renal cell carcinoma in Caucasian patients.
Anticancer research - 1 Dec 2009
Bachmann Hagen S, Rübben Herbert, Schmid Kurt W, Siffert Winfried, Riemann Kathrin
Abstract excerpt
BACKGROUND: The human X-ray repair cross-complementing group 1 (XRCC1) enzyme plays an important role in response to DNA damage. Two common polymorphisms in XRCC1, Arg194Trp and Arg399Gln, have been repeatedly associated with risk for and outcome of numerous types of cancer treated with radio- and chemotherapy. Recently, a Japanese study suggested these polymorphisms both as risk factors and outcome predictors in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
